Trump administration to begin delivering Regeneron COVID treatment on Tuesday

The federal government will begin distributing doses of Regeneron’s antibody drug treatment for COVID-19 on Tuesday, top health officials said.

During a call with reporters, Health and Human Services (HHS) Secretary Alex Azar said the administration will distribute 30,000 doses of the drug, with more coming in the weeks ahead.

The company expects to produce 300,000 doses by early January.

In July, the Trump administration’s Operation Warp Speed gave Regeneron $450 million to support manufacturing of the drug.

The limited allocations to state and territorial health departments will be proportionally based on confirmed COVID-19 cases over the previous seven day period. The information is based on data that hospitals and state health departments submit to the HHS COVID-19 response data hub.